Peer-Reviewed Paper Calls for Stronger Safety Standards for Modified mRNA Vaccines
The paper cites COVID-19 experience in raising questions about manufacturing, biological persistence and long-term safety.
The paper cites COVID-19 experience in raising questions about manufacturing, biological persistence and long-term safety.